Date Filed | Type | Description |
08/15/2023 |
4
| Roberts Brandi (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.
Txns:
| Bought 20,000 shares
@ $0.25, valued at
$5k
|
|
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/30/2022 |
4
| Roberts Brandi (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.
Txns:
| Granted 20,968 options to buy
@ $0.85, valued at
$17.8k
|
|
02/11/2022 |
4
| Roberts Brandi (CFO) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 90,000 options to buy
@ $4.2, valued at
$378k
|
|
03/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/15/2019 |
4
| Roberts Brandi (CFO & SVP, Finance) has filed a Form 4 on Lineage Cell Therapeutics, Inc.
Txns:
| Bought 5,000 shares
@ $1.01, valued at
$5.1k
|
|
07/02/2019 |
4
| Roberts Brandi (CFO & SVP, Finance) has filed a Form 4 on BIOTIME INC
Txns:
| Granted 150,000 options to buy
@ $1.1, valued at
$165k
|
|
01/09/2019 |
4
| Roberts Brandi (CFO & SVP, Finance) has filed a Form 4 on BIOTIME INC
Txns:
| Granted 500,000 options to buy
@ $1.08, valued at
$540k
|
|
01/09/2019 |
3
| Roberts Brandi (CFO & SVP, Finance) has filed a Form 3 on BIOTIME INC |
07/02/2018 |
4
| Roberts Brandi (SVP & CFO) has filed a Form 4 on REVA Medical, Inc.
Txns:
| Bought 4,908 shares
@ $1.53, valued at
$7.5k
|
|
01/23/2018 |
4
| Roberts Brandi (SVP & CFO) has filed a Form 4 on REVA Medical, Inc.
Txns:
| Granted 50,000 shares
@ $0 Granted 100,000 options to buy
@ $3.875, valued at
$387.5k
|
|
09/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/30/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/23/2017 |
4
| Roberts Brandi (CFO & SVP) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Granted 889,926 restricted stock units
@ $0 |
|
01/06/2016 |
4
| Roberts Brandi (CFO & SVP) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Granted 572,700 options to buy
@ $0.42, valued at
$240.5k
|
|
06/12/2015 |
4
| Roberts Brandi (CFO & SVP) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Granted 444,400 options to buy
@ $0.5, valued at
$222.2k
|
|
03/30/2015 |
4
| Roberts Brandi (CFO & SVP) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Bought 20,000 shares
@ $0.5016, valued at
$10k
Bought 18,000 shares
@ $0.4972, valued at
$8.9k
|
|
01/02/2015 |
4
| Roberts Brandi (CFO & SVP) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Granted 722,800 options to buy
@ $0.58, valued at
$419.2k
|
|
06/20/2014 |
4
| Roberts Brandi (CFO & SVP) has filed a Form 4 on Mast Therapeutics, Inc.
Txns:
| Granted 336,600 options to buy
@ $0.65, valued at
$218.8k
|
|
01/03/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/21/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/03/2013 |
4
| Roberts Brandi (CFO & SVP) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC
Txns:
| Granted 75,750 options to buy
@ $0.59, valued at
$44.7k
|
|
12/09/2011 |
4
| Roberts Brandi (Vice President, Finance) has filed a Form 4 on ADVENTRX PHARMACEUTICALS INC
Txns:
| Granted 140,000 options to buy
@ $0.6, valued at
$84k
|
|
03/23/2011 |
3
| Roberts Brandi (Vice President, Finance) has filed a Form 3 on ADVENTRX PHARMACEUTICALS INC |